NCT00371813View on ClinicalTrials.gov

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

PHASE3CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

June 30, 2007

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline tartrate

DRUG

Placebo

Trial Locations (14)

10330

Pfizer Investigational Site, Bangkok

50200

Pfizer Investigational Site, Chiang Mai

100020

Pfizer Investigational Site, Beijing

100029

Pfizer Investigational Site, Beijing

100036

Pfizer Investigational Site, Beijing

100853

Pfizer Investigational Site, Beijing

110001

Pfizer Investigational Site, Shenyang

110016

Pfizer Investigational Site, Shenyang

159964

Pfizer Investigational Site, Singapore

169608

Pfizer Investigational Site, Singapore

200233

Pfizer Investigational Site, Shanghai

228310

Pfizer Investigational Site, Singapore

300052

Pfizer Investigational Site, Tanjin

510120

Pfizer Investigational Site, Guangzhou

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY